The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) Study

被引:50
|
作者
Durovni, Betina [2 ,3 ]
Cavalcante, Solange C. [2 ,4 ]
Saraceni, Valeria [2 ]
Vellozo, Vitoria [2 ]
Israel, Giselle [2 ]
King, Bonnie S. [5 ]
Cohn, Silvia [1 ]
Efron, Anne [5 ]
Pacheco, Antonio G. [4 ]
Moulton, Lawrence H. [5 ]
Chaisson, Richard E. [1 ,5 ,6 ]
Golub, Jonathan E. [1 ,6 ]
机构
[1] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21231 USA
[2] Municipal Hlth Secretariat, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil
[4] Fiocruz MS, BR-21045900 Rio De Janeiro, Brazil
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[6] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
adherence; HIV; implementation; isoniazid preventive therapy; tuberculosis; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTED PATIENTS; DE-JANEIRO; TUBERCULOSIS; BRAZIL; TRIAL; RISK; IMPACT;
D O I
10.1097/01.aids.0000391022.95412.a6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: The TB/HIV in Rio (THRio) study was launched in September 2005 to assess the impact of integrated tuberculosis (TB) and HIV treatment strategies in 29 HIV clinics in Rio de Janeiro, Brazil. Design: THRio is a cluster-randomized trial (CRT) to determine whether routine screening for and treatment of latent TB in HIV clinic patients with access to anti-retroviral therapy will reduce TB incidence at the clinic level. THRio is part of the Consortium to Respond Effectively to AIDS/TB Epidemic that is implementing research studies to assess the impact of bold, new public health paradigms for controlling the AIDS/TB epidemic. Methods: Twenty-nine public primary HIV clinics were randomly assigned a date to begin implementing TB screening procedures and provision of isoniazid preventive therapy (IPT) for TB/HIVcoinfected patients. Final analysis of the CRT is expected in 2011. Results: Starting at date of tuberculin skin test (TST)/IPT implementation at each clinic through August 2010, 1670 HIV-infected patients initiated IPT, of which 215 are still receiving treatment. Of the remaining 1455 patients, 1230 (85%) completed therapy and only 20 (1.2%) patients initiating IPT reported adverse reactions leading to discontinuation of therapy. IPT completion was higher among HIV-infected patients receiving HAART (87%) than those not yet receiving HAART (79%, P < 0.01). Times to TST and IPT have markedly decreased postintervention, but remain considerably long. The richness of the THRio database has resulted in several analyses of this expansive cohort of HIV-infected patients that are reviewed here. Conclusions: The national implementation of TST and IPT for HIV-positive patients in Brazil has been invigorated partly due to THRio's baseline results. Expanded use of IPT in HIV patients in Rio de Janeiro is achievable with high adherence and low adverse events, although this effort requires a package of activities including training, advocacy and reorganization of services. (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:S49 / S56
页数:8
相关论文
共 50 条
  • [31] Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy
    van Griensven, Johan
    Choun, Kimcheng
    Chim, Bopha
    Thai, Sopheak
    Lorent, Natalie
    Lynen, Lutgarde
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 (12) : 1823 - 1831
  • [32] The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil
    Golub, Jonathan E.
    Saraceni, Valeria
    Cavalcante, Solange C.
    Pacheco, Antonio G.
    Moulton, Lawrence H.
    King, Bonnie S.
    Efron, Anne
    Moore, Richard D.
    Chaisson, Richard E.
    Durovni, Betina
    [J]. AIDS, 2007, 21 (11) : 1441 - 1448
  • [33] Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study
    Henok Tadesse Ayele
    Maaike SM van Mourik
    Marc JM Bonten
    [J]. BMC Infectious Diseases, 15
  • [34] Predictors of adherence to isoniazid preventive therapy in HIV patients in Ethiopia: A prospective cohort study
    Ayele, H. T.
    Mourik, M. S. V.
    Bonten, M.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 45 : 386 - 386
  • [35] Mortality benefit of isoniazid preventive therapy in HIV-positive persons: a simulation study
    Bachhuber, M. A.
    Gross, R.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (08) : 1038 - 1040
  • [36] Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study
    Ayele, Henok Tadesse
    van Mourik, Maaike Sm
    Bonten, Marc J. M.
    [J]. BMC INFECTIOUS DISEASES, 2015, 15
  • [37] Factors affecting the acceptability of isoniazid preventive therapy among healthcare providers in selected HIV clinics in Nairobi County, Kenya: a qualitative study
    Wambiya, Elvis Omondi Achach
    Atela, Martin
    Eboreime, Ejemai
    Ibisomi, Latifat
    [J]. BMJ OPEN, 2018, 8 (12):
  • [38] Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania (vol 20, 738, 2020)
    Hunter, Olivia F.
    Kyesi, Furaha
    Ahluwalia, Amrit Kaur
    Daffe, Zeinabou Niame
    Munseri, Patricia
    von Reyn, C. Fordham
    Adams, Lisa V.
    [J]. BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [39] Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women
    Gupta, Amita
    Montepiedra, Grace
    Aaron, Lisa
    Theron, Gerhard
    McCarthy, Katie
    Bradford, Sarah
    Chipato, Tsungai
    Vhembo, Tichaona
    Stranix-Chibanda, Lynda
    Onyango-Makumbi, Carolyne
    Masheto, Gaerolwe R.
    Violari, Avy
    Mmbaga, Blandina T.
    Aurpibul, Linda
    Bhosale, Ramesh
    Mave, Vidya
    Rouzier, Vanessa
    Hesseling, Anneke
    Shin, Katherine
    Zimmer, Bonnie
    Costello, Diane
    Sterling, Timothy R.
    Chakhtoura, Nahida
    Jean-Philippe, Patrick
    Weinberg, Adriana
    Kabugho, Enid
    Kaganzi, Hellen
    Kataike, Hajira
    Maena, Joel
    Wabwire, Deo
    Chanaiwa, Vongai
    Mandima, Patricia
    Maonera, Suzen
    Marote, Emmie
    Maturure, Sukunena
    Mbengeranwa, Tapiwa
    Mhembere, Tsungai
    Mutambanengwe, Mercy
    Nematadzira, Teacler
    Abrahams, Nasreen
    Cassim, Haseena
    Louw, Jeanne
    Mathiba, Ruth
    Mbaba, Sharon
    Nyati, Mandisa
    du Preez, Karen
    Rossouw, Lindie
    Rossouw, Magdel
    Smuts, Marlize
    de Vaal, Celeste
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (14): : 1333 - 1346
  • [40] Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia
    Ayele, H. T.
    van Mourik, M. S. M.
    Bonten, M. J. M.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (10) : 1342 - 1347